Viewing Study NCT04936295


Ignite Creation Date: 2025-12-24 @ 1:12 PM
Ignite Modification Date: 2025-12-31 @ 9:58 AM
Study NCT ID: NCT04936295
Status: UNKNOWN
Last Update Posted: 2021-06-23
First Post: 2021-06-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fulvestrant Plus Anlotinib in HR(+)/HER2(-) Metastatic Breast Cancer With FGFR Mutation
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module